BioMarCare is a portfolio company of Hadasit Bio-Holdings, a publicly traded holding company for businesses using intellectual property developed and owned by Israel's Hadassah University Hospital.

Israel-listed Micromedic has invested $1m in BioMarCare Technologies, with an option to invest an additional $1m in the local biotech company.

BioMarCare is a portfolio company of Hadasit Bio-Holdings, a publicly traded holding company for businesses using intellectual property developed and owned by Israel’s Hadassah University Hospital.

Ophir Shahaf, chief executive of Hadasit Bio-Holdings, said: "The investment validates the technology and research behind BioMarCare’s diagnostic kits.

"Not only will the agreement secure funds to advance the research and development of its kits, but more importantly, it will allow for collaboration between the companies with significant synergies utilizing resources, expertise and knowledge that the companies have acquired in the field of cancer diagnostics."

The deal is part of a share crossholding in Israel.

In September, BioLight Israeli Life Sciences Investments, a company currently chaired by Israel Makov, former executive president of Israel-based drugs group Teva Pharmaceuticals, and managed…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?